Evidence map›Paper›PMID 19577533›Full record

ArticleAnalytical biochemistry2009

Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.

Irena Ivnitski-Steele, Ann R Holmes, Erwin Lamping, Brian C Monk, Richard D Cannon, Larry A Sklar

Abstract read
In one paragraph

Article in Analytical biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Deletion ofmSphere · 2025
    Article
  3. Antimicrobial agents and chemotherapy · 2025
    Article
  4. Article
  5. Combining Fluconazole with Benzo[Molecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Antifungal activity of β-lapachone against a fluconazole-resistant Candida auris strain.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  8. Article
  9. Overcoming Drug Resistance in a ClinicalAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Clorgyline Analogs Synergize with Azoles against Drug Efflux inJournal of fungi (Basel, Switzerland) · 2023
    Article
  11. Atazanavir Resensitizes Candida auris to Azoles.Antimicrobial agents and chemotherapy · 2023
    Article
  12. Functional Expression of RecombinantJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Tyrosol induces multiple drug resistance in yeastFrontiers in microbiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinicalSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  20. Curcumin affects function of Hsp90 and drug efflux pump ofFrontiers in cellular and infection microbiology · 2022
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Irena Ivnitski-SteeleNew Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, NM 87131, USA. iivnitski@salud.unm.edu
Ann R Holmes
Erwin Lamping
Brian C Monk
Richard D Cannon
Larry A Sklar
University of Otago · NZUniversity of New Mexico · US

Funding

Yeast Biology ConsortiumU54MH084690 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI SKLAR, LARRY A. · 2008 to 2013
$14.4M
Fungal transporters: from resistance to new antifungalsR01DE016885 · NIDCR · UNIVERSITY OF OTAGO · PI CANNON, RICHARD D · 2005 to 2008
$927k
NIDCR NIH HHS R01 DE016885NIDCR NIH HHS R01DE016885-01NIMH NIH HHS IU54 MH084690-01NIMH NIH HHS U54 MH084690
6 · The paper itself

Abstract

Clinically relevant azole resistance in the fungal pathogen Candida albicans is most often associated with the increased expression of plasma membrane efflux pumps, specifically the ATP-binding cassette (ABC) transporters CaCdr1p and CaCdr2p and the major facilitator superfamily (MFS) transporter CaMdr1p. Development of potent pump inhibitors that chemosensitize cells to azoles is a promising approach to overcome antifungal resistance. Here we identify Nile red as a new fluorescent substrate for CaCdr1p, CaCdr2p, and CaMdr1p. Nile red was effluxed efficiently from Saccharomyces cerevisiae cells heterologously expressing these transporters. Enniatin selectively inhibited the efflux of Nile red from S. cerevisiae cells expressing CaCdr1p or CaMdr1p but not from cells expressing CaCdr2p. This indicates that Nile red can be used for the identification of inhibitors specific for particular transporters mediating antifungal resistance in pathogenic yeast.

Indexed as

Candida albicansATP Binding Cassette Transporter, Subfamily B, Member 1Biological TransportDepsipeptidesFluorescent DyesFungal ProteinsOxazinesRhodaminesATP Binding Cassette Transporter, Subfamily B, Member 1DepsipeptidesenniatinsFluorescent DyesFungal Proteinsnile redOxazinesrhodamine 6GRhodamines

Identifiers

PMID19577533
PMCPMC2739806
OpenAlexW2000303873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.